Skip to main content
Top
Published in: Intensive Care Medicine 1/2016

01-01-2016 | Review

Cholestatic liver (dys)function during sepsis and other critical illnesses

Authors: Marc Jenniskens, Lies Langouche, Yoo-Mee Vanwijngaerden, Dieter Mesotten, Greet Van den Berghe

Published in: Intensive Care Medicine | Issue 1/2016

Login to get access

Abstract

Objective

In ICU patients, abnormal liver tests are common. Markers of cholestasis are associated with adverse outcome. Research has focused on the possibility that mild hyperbilirubinemia, instead of indicating inadvertent cholestasis, may be adaptive and beneficial. These new insights are reviewed and integrated in the state-of-the-art knowledge on hepatobiliary alterations during sepsis and other critical illnesses.

Data sources

Relevant publications were searched in Medline with search terms bile, bile acids, cholestasis, critical illness, intensive care, sepsis, alone or in combination.

Data synthesis

Studies have shown that bilirubin, but also bile acids, the main active constitutes of bile, are increased in plasma of patients with critical illnesses. In particular the conjugated fractions of bilirubin and bile acids are high, indicating that during critical illness the liver is capable of converting these molecules to less toxic forms. In human liver biopsies of prolonged critically ill patients, expression of bile acid excretion pumps towards the bile canaliculi was lower, while alternative transporters towards the systemic circulation were upregulated. Remarkably, in the presence of increased circulating bile acids, expression of enzymes controlling synthesis of bile acids was not suppressed. This suggested loss of feedback inhibition of bile acids synthesis, possibly explained by the observed cytoplasmic retention of the nuclear FXR/RXR heterodimer. As macronutrient restriction during acute critical illness, an intervention that improved outcome, was found to further increase plasma bilirubin while reducing other markers of cholestasis, a potentially protective role of hyperbilirubinemia was suggested.

Conclusion

The increase in circulating levels of conjugated bile acids and bilirubin in response to acute sepsis/critical illnesses may not necessarily point to cholestasis as a pathophysiological entity. Instead it may be the result of an adaptively altered bile acid production and transport back towards the systemic circulation. How these changes could be beneficial for survival should be further investigated.
Literature
2.
go back to reference Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH, Austrian Epidemiologic Study on Intensive Care ASDI Study Group (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 35:1099–1104CrossRefPubMed Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH, Austrian Epidemiologic Study on Intensive Care ASDI Study Group (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 35:1099–1104CrossRefPubMed
3.
go back to reference Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schöniger-Hekele M, Madl C, Schenk P (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302–1310CrossRefPubMed Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schöniger-Hekele M, Madl C, Schenk P (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302–1310CrossRefPubMed
4.
go back to reference Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) ‘Liver function tests’ on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411CrossRefPubMed Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) ‘Liver function tests’ on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411CrossRefPubMed
5.
go back to reference Horvatits T, Trauner M, Fuhrmann V (2013) Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 19:128–132CrossRefPubMed Horvatits T, Trauner M, Fuhrmann V (2013) Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 19:128–132CrossRefPubMed
7.
go back to reference Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T (2006) Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 32:267–274CrossRefPubMed Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T (2006) Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 32:267–274CrossRefPubMed
8.
go back to reference Harbrecht BG, Zenati MS, Doyle HR, McMichael J, Townsend RN, Clancy KD, Peitzman AB (2002) Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 53:517–523CrossRefPubMed Harbrecht BG, Zenati MS, Doyle HR, McMichael J, Townsend RN, Clancy KD, Peitzman AB (2002) Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 53:517–523CrossRefPubMed
9.
go back to reference Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A (2009) The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 94:2345–2352CrossRefPubMed Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A (2009) The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab 94:2345–2352CrossRefPubMed
10.
go back to reference van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90CrossRefPubMed van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90CrossRefPubMed
11.
go back to reference Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR (2000) Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 174:973–977CrossRefPubMed Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR (2000) Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 174:973–977CrossRefPubMed
12.
go back to reference Murray FE, Stinchcombe SJ, Hawkey CJ (1992) Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study. Gut 33:1123–1125PubMedCentralCrossRefPubMed Murray FE, Stinchcombe SJ, Hawkey CJ (1992) Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study. Gut 33:1123–1125PubMedCentralCrossRefPubMed
13.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMed
14.
go back to reference Trauner M, Fickert P, Stauber RE (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14:946–959CrossRefPubMed Trauner M, Fickert P, Stauber RE (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14:946–959CrossRefPubMed
15.
go back to reference Grau T, Bonet A, Rubio M, Mateo D, Farré M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A, Working Group on Nutrition and Metabolism of the Spanish Society of Critical Care (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11:R10PubMedCentralCrossRefPubMed Grau T, Bonet A, Rubio M, Mateo D, Farré M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A, Working Group on Nutrition and Metabolism of the Spanish Society of Critical Care (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11:R10PubMedCentralCrossRefPubMed
16.
go back to reference Lat I, Foster DR, Erstad B (2010) Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med 38:S175–S187CrossRefPubMed Lat I, Foster DR, Erstad B (2010) Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med 38:S175–S187CrossRefPubMed
17.
go back to reference Porez G, Prawitt J, Gross B, Staels B (2012) Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 53:1723–1737PubMedCentralCrossRefPubMed Porez G, Prawitt J, Gross B, Staels B (2012) Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 53:1723–1737PubMedCentralCrossRefPubMed
19.
go back to reference Kubitz R, Droge C, Stindt J, Weissenberger K, Haussinger D (2012) The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 36:536–553CrossRefPubMed Kubitz R, Droge C, Stindt J, Weissenberger K, Haussinger D (2012) The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 36:536–553CrossRefPubMed
20.
go back to reference Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 24:1803–1823CrossRefPubMed Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 24:1803–1823CrossRefPubMed
21.
go back to reference Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791CrossRefPubMed Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791CrossRefPubMed
22.
go back to reference Denk GU, Soroka CJ, Takeyama Y, Chen W-S, Schuetz JD, Boyer JL (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 40:585–591CrossRefPubMed Denk GU, Soroka CJ, Takeyama Y, Chen W-S, Schuetz JD, Boyer JL (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 40:585–591CrossRefPubMed
23.
go back to reference Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL (2001) Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121:1473–1484CrossRefPubMed Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL (2001) Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121:1473–1484CrossRefPubMed
24.
go back to reference Glass CK, Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44–55CrossRefPubMed Glass CK, Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44–55CrossRefPubMed
25.
go back to reference Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517–526CrossRefPubMed Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517–526CrossRefPubMed
26.
go back to reference Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507–515CrossRefPubMed Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507–515CrossRefPubMed
27.
go back to reference Tirona RG, Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169–1186CrossRefPubMed Tirona RG, Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169–1186CrossRefPubMed
28.
go back to reference Chiang JYL (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284:G349–G356CrossRefPubMed Chiang JYL (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284:G349–G356CrossRefPubMed
29.
30.
go back to reference Glicksman C, Pournaras DJ, Wright M, Roberts R, Mahon D, Welbourn R, Sherwood R, Alaghband-Zadeh J, le Roux CW (2010) Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 47:482–484CrossRefPubMed Glicksman C, Pournaras DJ, Wright M, Roberts R, Mahon D, Welbourn R, Sherwood R, Alaghband-Zadeh J, le Roux CW (2010) Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 47:482–484CrossRefPubMed
32.
go back to reference Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678–693CrossRefPubMed Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678–693CrossRefPubMed
34.
go back to reference Schaap FG, Trauner M, Jansen PLM (2014) Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 11:55–67CrossRefPubMed Schaap FG, Trauner M, Jansen PLM (2014) Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 11:55–67CrossRefPubMed
37.
go back to reference Hirata K, Ikeda S, Honma T, Mitaka T, Furuhata T, Katsuramaki T, Hata F, Mukaiya M (2001) Sepsis and cholestasis: basic findings in the sinusoid and bile canaliculus. J Hepatobiliary Pancreatic Surg 8:20–26CrossRef Hirata K, Ikeda S, Honma T, Mitaka T, Furuhata T, Katsuramaki T, Hata F, Mukaiya M (2001) Sepsis and cholestasis: basic findings in the sinusoid and bile canaliculus. J Hepatobiliary Pancreatic Surg 8:20–26CrossRef
38.
go back to reference Koskinas J, Gomatos IP, Tiniakos DG, Memos N, Boutsikou M, Garatzioti A, Archimandritis A, Betrosian A (2008) Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 14:1389–1393PubMedCentralCrossRefPubMed Koskinas J, Gomatos IP, Tiniakos DG, Memos N, Boutsikou M, Garatzioti A, Archimandritis A, Betrosian A (2008) Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 14:1389–1393PubMedCentralCrossRefPubMed
39.
go back to reference Lysova NL, Gurevich LE, Trusov OA, Shchegolev AI, Mishnev OD (2001) Immunohistochemical characteristics of the liver in patients with peritonitis (early autopsy). Bull Exp Biol Med 132:1125–1129CrossRefPubMed Lysova NL, Gurevich LE, Trusov OA, Shchegolev AI, Mishnev OD (2001) Immunohistochemical characteristics of the liver in patients with peritonitis (early autopsy). Bull Exp Biol Med 132:1125–1129CrossRefPubMed
40.
go back to reference Lefkowitch JH (1982) Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and “cholangitis lenta”. Hum Pathol 13:19–24CrossRefPubMed Lefkowitch JH (1982) Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and “cholangitis lenta”. Hum Pathol 13:19–24CrossRefPubMed
41.
go back to reference Trauner M, Meier PJ, Boyer JL (1998) Molecular pathogenesis of cholestasis. New Engl J Med 339:1217–1227CrossRefPubMed Trauner M, Meier PJ, Boyer JL (1998) Molecular pathogenesis of cholestasis. New Engl J Med 339:1217–1227CrossRefPubMed
42.
go back to reference Jaeger C, Mayer G, Henrich R, Gossner L, Rabenstein T, May A, Guenter E, Ell C (2006) Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy 38:730–734CrossRefPubMed Jaeger C, Mayer G, Henrich R, Gossner L, Rabenstein T, May A, Guenter E, Ell C (2006) Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy 38:730–734CrossRefPubMed
43.
go back to reference Kulaksiz H, Heuberger D, Engler S, Stiehl A (2008) Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40:214–218CrossRefPubMed Kulaksiz H, Heuberger D, Engler S, Stiehl A (2008) Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40:214–218CrossRefPubMed
44.
go back to reference Green RM, Beier D, Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111:193–198CrossRefPubMed Green RM, Beier D, Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111:193–198CrossRefPubMed
45.
go back to reference Vanwijngaerden YM, Wauters J, Langouche L, Vander Perre S, Liddle C, Coulter S, Vanderborght S, Roskams T, Wilmer A, Van den Berghe G, Mesotten D (2011) Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 54:1741–1752CrossRefPubMed Vanwijngaerden YM, Wauters J, Langouche L, Vander Perre S, Liddle C, Coulter S, Vanderborght S, Roskams T, Wilmer A, Van den Berghe G, Mesotten D (2011) Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 54:1741–1752CrossRefPubMed
46.
go back to reference Andrejko KM, Raj NR, Kim PK, Cereda M, Deutschman CS (2008) IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 29:490–496PubMedCentralPubMed Andrejko KM, Raj NR, Kim PK, Cereda M, Deutschman CS (2008) IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 29:490–496PubMedCentralPubMed
47.
go back to reference Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, Suchy FJ, Matern S, Gartung C (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831–G841CrossRefPubMed Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, Suchy FJ, Matern S, Gartung C (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831–G841CrossRefPubMed
48.
go back to reference Cherrington NJ, Slitt AL, Li N, Klaassen CD (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734–741CrossRefPubMed Cherrington NJ, Slitt AL, Li N, Klaassen CD (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734–741CrossRefPubMed
49.
go back to reference Elferink MGL, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJH, Meijer DKF, Groothuis GMM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008–G1016CrossRefPubMed Elferink MGL, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJH, Meijer DKF, Groothuis GMM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008–G1016CrossRefPubMed
50.
go back to reference Donner MG, Warskulat U, Saha N, Häussinger D (2004) Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385:331–339CrossRefPubMed Donner MG, Warskulat U, Saha N, Häussinger D (2004) Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385:331–339CrossRefPubMed
51.
go back to reference Vanwijngaerden Y-M, Langouche L, Derde S, Liddle C, Coulter S, Van den Berghe G, Mesotten D (2014) Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness. Shock 41:48–54CrossRefPubMed Vanwijngaerden Y-M, Langouche L, Derde S, Liddle C, Coulter S, Van den Berghe G, Mesotten D (2014) Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness. Shock 41:48–54CrossRefPubMed
52.
go back to reference Zimmerman TL, Thevananther S, Ghose R, Burns AR, Karpen SJ (2006) Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281:15434–15440CrossRefPubMed Zimmerman TL, Thevananther S, Ghose R, Burns AR, Karpen SJ (2006) Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281:15434–15440CrossRefPubMed
53.
go back to reference Geier A, Fickert P, Trauner M (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574–585CrossRefPubMed Geier A, Fickert P, Trauner M (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574–585CrossRefPubMed
54.
55.
go back to reference Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ (1996) Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39:587–593PubMedCentralCrossRefPubMed Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ (1996) Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39:587–593PubMedCentralCrossRefPubMed
56.
go back to reference te Boekhorst T, Urlus M, Doesburg W, Yap SH, Goris RJ (1988) Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J Hepatol 7:111–117CrossRef te Boekhorst T, Urlus M, Doesburg W, Yap SH, Goris RJ (1988) Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. J Hepatol 7:111–117CrossRef
57.
go back to reference Carter BA, Shulman RJ (2007) Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 4:277–287CrossRefPubMed Carter BA, Shulman RJ (2007) Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 4:277–287CrossRefPubMed
58.
go back to reference Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G (2011) Early versus late parenteral nutrition in critically ill adults. New Engl J Med 365:506–517CrossRefPubMed Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G (2011) Early versus late parenteral nutrition in critically ill adults. New Engl J Med 365:506–517CrossRefPubMed
59.
go back to reference Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, Meersseman P, Derese I, Mesotten D, Wouters PJ, Van Cromphaut S, Debaveye Y, Gosselink R, Gunst J, Wilmer A, Van den Berghe G, Vanhorebeek I (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621–629CrossRefPubMed Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, Meersseman P, Derese I, Mesotten D, Wouters PJ, Van Cromphaut S, Debaveye Y, Gosselink R, Gunst J, Wilmer A, Van den Berghe G, Vanhorebeek I (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621–629CrossRefPubMed
60.
go back to reference Vanwijngaerden Y-M, Langouche L, Brunner R, Debaveye Y, Gielen M, Casaer M, Liddle C, Coulter S, Wouters PJ, Wilmer A, Van den Berghe G, Mesotten D (2013) Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge. Hepatology ;60:202–610 Vanwijngaerden Y-M, Langouche L, Brunner R, Debaveye Y, Gielen M, Casaer M, Liddle C, Coulter S, Wouters PJ, Wilmer A, Van den Berghe G, Mesotten D (2013) Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge. Hepatology ;60:202–610
61.
go back to reference Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. New Engl J Med 354:449–461CrossRefPubMed Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. New Engl J Med 354:449–461CrossRefPubMed
62.
go back to reference Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. New Engl J Med 345:1359–1367CrossRefPubMed Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. New Engl J Med 345:1359–1367CrossRefPubMed
63.
go back to reference Gonnert FA, Recknagel P, Hilger I, Claus RA, Bauer M, Kortgen A (2013) Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care 17:R67PubMedCentralCrossRefPubMed Gonnert FA, Recknagel P, Hilger I, Claus RA, Bauer M, Kortgen A (2013) Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care 17:R67PubMedCentralCrossRefPubMed
64.
go back to reference Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, Dyson A, Carré JE, Kortgen A, Krafft C, Popp J, Sponholz C, Fuhrmann V, Hilger I, Claus RA, Riedemann NC, Wetzker R, Singer M, Trauner M, Bauer M (2012) Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 9:e1001338PubMedCentralCrossRefPubMed Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, Dyson A, Carré JE, Kortgen A, Krafft C, Popp J, Sponholz C, Fuhrmann V, Hilger I, Claus RA, Riedemann NC, Wetzker R, Singer M, Trauner M, Bauer M (2012) Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 9:e1001338PubMedCentralCrossRefPubMed
65.
go back to reference Yang K, Köck K, Sedykh A, Tropsha A, Brouwer KLR (2013) An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 102:3037–3057PubMedCentralCrossRefPubMed Yang K, Köck K, Sedykh A, Tropsha A, Brouwer KLR (2013) An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 102:3037–3057PubMedCentralCrossRefPubMed
66.
go back to reference Lammert C, Bjornsson E, Niklasson A, Chalasani N (2010) Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51:615–620CrossRefPubMed Lammert C, Bjornsson E, Niklasson A, Chalasani N (2010) Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51:615–620CrossRefPubMed
67.
go back to reference Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, Higashi Y (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126:598–603CrossRefPubMed Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, Higashi Y (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126:598–603CrossRefPubMed
68.
go back to reference Castilho Á, Aveleira CA, Leal EC, Simões NF, Fernandes CR, Meirinhos RI, Baptista FI, Ambrósio AF (2012) Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS One 7:e42428PubMedCentralCrossRefPubMed Castilho Á, Aveleira CA, Leal EC, Simões NF, Fernandes CR, Meirinhos RI, Baptista FI, Ambrósio AF (2012) Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS One 7:e42428PubMedCentralCrossRefPubMed
69.
70.
go back to reference Wang WW, Smith DLH, Zucker SD (2004) Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40:424–433CrossRefPubMed Wang WW, Smith DLH, Zucker SD (2004) Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40:424–433CrossRefPubMed
71.
go back to reference Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, Maemura K, LeBlanc BW, Marino K, Doerschuk CM, Yet SF, Lee ME, Perrella MA (2000) Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102:3015–3022CrossRefPubMed Wiesel P, Patel AP, DiFonzo N, Marria PB, Sim CU, Pellacani A, Maemura K, LeBlanc BW, Marino K, Doerschuk CM, Yet SF, Lee ME, Perrella MA (2000) Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102:3015–3022CrossRefPubMed
72.
go back to reference McNeilly AD, Macfarlane DP, O’Flaherty E, Livingstone DE, Mitić T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, Skøtt O, Walker BR, Andrew R (2010) Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol 52:705–711PubMedCentralCrossRefPubMed McNeilly AD, Macfarlane DP, O’Flaherty E, Livingstone DE, Mitić T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, Skøtt O, Walker BR, Andrew R (2010) Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol 52:705–711PubMedCentralCrossRefPubMed
73.
go back to reference Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden YM, Spriet I, Wouters PJ, Vander Perre S, Langouche L, Vanhorebeek I, Walker BR, Van den Berghe G (2013) Reduced cortisol metabolism during critical illness. New Engl J Med 368:1477–1488PubMedCentralCrossRefPubMed Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden YM, Spriet I, Wouters PJ, Vander Perre S, Langouche L, Vanhorebeek I, Walker BR, Van den Berghe G (2013) Reduced cortisol metabolism during critical illness. New Engl J Med 368:1477–1488PubMedCentralCrossRefPubMed
74.
go back to reference Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484–489CrossRefPubMed Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484–489CrossRefPubMed
75.
go back to reference Katsuma S, Hirasawa A, Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386–390CrossRefPubMed Katsuma S, Hirasawa A, Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386–390CrossRefPubMed
76.
go back to reference Alsatie M, Kwo PY, Gingerich JR, Qi R, Eckert G, Cummings OW, Imperiale TF (2007) A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C. J Clin Gastroenterol 41:416–421CrossRefPubMed Alsatie M, Kwo PY, Gingerich JR, Qi R, Eckert G, Cummings OW, Imperiale TF (2007) A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C. J Clin Gastroenterol 41:416–421CrossRefPubMed
77.
go back to reference Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940–946PubMedCentralCrossRefPubMed Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940–946PubMedCentralCrossRefPubMed
78.
go back to reference Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289–298PubMedCentralCrossRefPubMed Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289–298PubMedCentralCrossRefPubMed
79.
go back to reference Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, Orth HM, Klindt C, Schuier M, Keitel V, Reich M, Liu G, Schmidt S, Xu HC, Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E, Lang F, Haussinger D, Lang KS, Foller M, Lang PA (2015) Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 61:275–284PubMedCentralCrossRefPubMed Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, Orth HM, Klindt C, Schuier M, Keitel V, Reich M, Liu G, Schmidt S, Xu HC, Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E, Lang F, Haussinger D, Lang KS, Foller M, Lang PA (2015) Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 61:275–284PubMedCentralCrossRefPubMed
80.
go back to reference Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, Lv H, Song JG, Wu FX, Yu WF (2011) Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology 114:1036–1047CrossRefPubMed Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, Lv H, Song JG, Wu FX, Yu WF (2011) Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology 114:1036–1047CrossRefPubMed
81.
go back to reference Zhao G, Shen X, Nan H, Yan L, Zhao H, Yu J, Lv Y (2013) Remifentanil protects liver against ischemia/reperfusion injury through activation of anti-apoptotic pathways. J Surg Res 183:827–834CrossRefPubMed Zhao G, Shen X, Nan H, Yan L, Zhao H, Yu J, Lv Y (2013) Remifentanil protects liver against ischemia/reperfusion injury through activation of anti-apoptotic pathways. J Surg Res 183:827–834CrossRefPubMed
82.
go back to reference Beuers U (2006) Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3:318–328CrossRefPubMed Beuers U (2006) Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3:318–328CrossRefPubMed
83.
go back to reference Zimmerman JE, Kramer AA, McNair DS, Malila FM (2006) Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med 34:1297–1310CrossRefPubMed Zimmerman JE, Kramer AA, McNair DS, Malila FM (2006) Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med 34:1297–1310CrossRefPubMed
84.
go back to reference Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed
Metadata
Title
Cholestatic liver (dys)function during sepsis and other critical illnesses
Authors
Marc Jenniskens
Lies Langouche
Yoo-Mee Vanwijngaerden
Dieter Mesotten
Greet Van den Berghe
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 1/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4054-0

Other articles of this Issue 1/2016

Intensive Care Medicine 1/2016 Go to the issue

From the Inside

An emotional awakening